var eventsData = [{"Ticker":"CFN","EffectiveDate":"2014-10-22","Type":"RatingNeutral","Title":"Raymond James downgrades CFN to Market Perform from Strong Buy; previously $52.","DailyReturn":0.000353,"FiveDayReturnAfter":0.011055,"FiveDayReturnBefore":-0.004927},{"Ticker":"CFN","EffectiveDate":"2014-10-07","Type":"RatingNeutral","Title":"JP Morgan downgrades CFN to Neutral from Overweight. Target Price is $59; previously $48.","DailyReturn":0.005286,"FiveDayReturnAfter":0.003518,"FiveDayReturnBefore":0.214369},{"Ticker":"CFN","EffectiveDate":"2014-10-06","Type":"RatingNeutral","Title":"PiperJaffray downgrades CFN to Neutral from Overweight. Target Price is $48; previously $38.","DailyReturn":0.229153,"FiveDayReturnAfter":0.214573,"FiveDayReturnBefore":0.009355},{"Ticker":"CFN","EffectiveDate":"2014-08-15","Type":"RatingNeutral","Title":"Raymond James maintains CFN to Strong Buy. Target Price is $52; previously $50.","DailyReturn":-0.001589,"FiveDayReturnAfter":0.022675,"FiveDayReturnBefore":0.044814},{"Ticker":"CFN","EffectiveDate":"2014-08-08","Type":"RatingNeutral","Title":"Stifel Nicolaus maintains CFN to Buy. Target Price is $49; previously $42.","DailyReturn":0.009024,"FiveDayReturnAfter":0.044814,"FiveDayReturnBefore":-0.03912},{"Ticker":"CFN","EffectiveDate":"2014-08-08","Type":"RatingNeutral","Title":"JP Morgan maintains CFN to Overweight. Target Price is $48; previously $44.","DailyReturn":0.009024,"FiveDayReturnAfter":0.044814,"FiveDayReturnBefore":-0.03912},{"Ticker":"CFN","EffectiveDate":"2014-08-08","Type":"RatingNeutral","Title":"BMO Capital maintains CFN to Outperform. Target Price is $48; previously $46.","DailyReturn":0.009024,"FiveDayReturnAfter":0.044814,"FiveDayReturnBefore":-0.03912},{"Ticker":"CFN","EffectiveDate":"2014-05-19","Type":"RatingNeutral","Title":"Raymond James maintains CFN to Strong Buy. Target Price is $50; previously $48.","DailyReturn":0.009355,"FiveDayReturnAfter":-0.011998,"FiveDayReturnBefore":0.042032},{"Ticker":"CFN","EffectiveDate":"2014-05-06","Type":"RatingUpgrade","Title":"Goldman Sachs upgrades CFN to Neutral from Sell. Target Price is $40; previously $37.","DailyReturn":-0.001523,"FiveDayReturnAfter":0.045898,"FiveDayReturnBefore":0.017157},{"Ticker":"CFN","EffectiveDate":"2014-05-06","Type":"RatingNeutral","Title":"Barclays maintains CFN to Equal-Weight. Target Price is $42; previously $44.","DailyReturn":-0.001523,"FiveDayReturnAfter":0.045898,"FiveDayReturnBefore":0.017157},{"Ticker":"CFN","EffectiveDate":"2013-12-18","Type":"RatingNeutral","Title":"Bank of America maintains CFN to Buy. Target Price is $45; previously $43.","DailyReturn":0.0265,"FiveDayReturnAfter":0.033468,"FiveDayReturnBefore":-0.025142},{"Ticker":"CFN","EffectiveDate":"2013-12-17","Type":"RatingNeutral","Title":"Goldman Sachs downgrades CFN to Sell from Neutral. Target Price is $36; previously $35.","DailyReturn":-0.025323,"FiveDayReturnAfter":0.001012,"FiveDayReturnBefore":-0.018813},{"Ticker":"CFN","EffectiveDate":"2013-11-07","Type":"EarningsRevenueBeat","Title":"After market close, CFN reports 2014 Q1's earning $0.44 per share and revenue $830MM. This beats analyst's estimated EPS $0.39, beats estimated revenue $818.69MM.","DailyReturn":-0.009845,"FiveDayReturnAfter":0.010052,"FiveDayReturnBefore":-0.005684},{"Ticker":"CFN","EffectiveDate":"2013-08-09","Type":"RatingNeutral","Title":"Stifel Nicolaus maintains CFN to Buy. Target Price is $42; previously $37.","DailyReturn":-0.009914,"FiveDayReturnAfter":-0.031298,"FiveDayReturnBefore":-0.04275},{"Ticker":"CFN","EffectiveDate":"2013-08-08","Type":"EarningsRevenueMiss","Title":"After market close, CFN reports 2013 Q4's earning $0.55 per share and revenue $903MM. This misses analyst's estimated EPS $0.56, misses estimated revenue $918.25MM.","DailyReturn":0.011108,"FiveDayReturnAfter":0.014526,"FiveDayReturnBefore":-0.043993},{"Ticker":"CFN","EffectiveDate":"2013-07-12","Type":"RatingNeutral","Title":"JP Morgan maintains CFN to Overweight. Target Price is $41; previously $35.","DailyReturn":0.001038,"FiveDayReturnAfter":0.007757,"FiveDayReturnBefore":0.029774},{"Ticker":"CFN","EffectiveDate":"2013-07-08","Type":"RatingNeutral","Title":"BMO Capital maintains CFN to Outperform. Target Price is $42; previously $48.","DailyReturn":0.017563,"FiveDayReturnAfter":0.025742,"FiveDayReturnBefore":0.019618},{"Ticker":"CFN","EffectiveDate":"2013-05-09","Type":"EarningsBeatRevenueMiss","Title":"After market close, CFN reports 2013 Q3's earning $0.59 per share and revenue $901MM. This beats analyst's estimated EPS $0.53, misses estimated revenue $907.8MM.","DailyReturn":0.000867,"FiveDayReturnAfter":-0.026933,"FiveDayReturnBefore":0.04158},{"Ticker":"CFN","EffectiveDate":"2013-04-12","Type":"RatingNeutral","Title":"Deutsche Bank maintains CFN to Hold. Target Price is $35; previously $34.","DailyReturn":-0.002826,"FiveDayReturnAfter":-0.034204,"FiveDayReturnBefore":0.017387},{"Ticker":"CFN","EffectiveDate":"2013-02-20","Type":"RatingNeutral","Title":"Barclays maintains CFN to Equal-Weight. Target Price is $36; previously $32.","DailyReturn":-0.010886,"FiveDayReturnAfter":-0.030084,"FiveDayReturnBefore":0.019542},{"Ticker":"CFN","EffectiveDate":"2013-02-08","Type":"RatingNeutral","Title":"Stifel Nicolaus maintains CFN to Buy. Target Price is $37; previously $33.","DailyReturn":0.000628,"FiveDayReturnAfter":0.028187,"FiveDayReturnBefore":0.025133},{"Ticker":"CFN","EffectiveDate":"2013-02-08","Type":"RatingNeutral","Title":"Barclays maintains CFN to Equal-Weight. Target Price is $32; previously $28.","DailyReturn":0.000628,"FiveDayReturnAfter":0.028187,"FiveDayReturnBefore":0.025133},{"Ticker":"CFN","EffectiveDate":"2013-02-08","Type":"RatingNeutral","Title":"Credit Agricole downgrades CFN to Outperform from Buy. Target Price is $36; previously $30.","DailyReturn":0.000628,"FiveDayReturnAfter":0.028187,"FiveDayReturnBefore":0.025133},{"Ticker":"CFN","EffectiveDate":"2013-02-08","Type":"RatingNeutral","Title":"BMO Capital maintains CFN to Outperform. Target Price is $35; previously $34.","DailyReturn":0.000628,"FiveDayReturnAfter":0.028187,"FiveDayReturnBefore":0.025133},{"Ticker":"CFN","EffectiveDate":"2013-02-07","Type":"EarningsRevenueBeat","Title":"After market close, CFN reports 2013 Q2's earning $0.54 per share and revenue $909MM. This beats analyst's estimated EPS $0.44, beats estimated revenue $908.4MM.","DailyReturn":0.012405,"FiveDayReturnAfter":0.019528,"FiveDayReturnBefore":0.009267},{"Ticker":"CFN","EffectiveDate":"2013-01-18","Type":"RatingNeutral","Title":"UBS maintains CFN to Buy. Target Price is $34; previously $32.","DailyReturn":0.009198,"FiveDayReturnAfter":0.009808,"FiveDayReturnBefore":0.026294},{"Ticker":"CFN","EffectiveDate":"2013-01-04","Type":"RatingNeutral","Title":"Deutsche Bank maintains CFN to Hold. Target Price is $32; previously $28.","DailyReturn":0.000344,"FiveDayReturnAfter":0.019067,"FiveDayReturnBefore":0.020491},{"Ticker":"CFN","EffectiveDate":"2013-01-03","Type":"RatingNeutral","Title":"Morgan Stanley downgrades CFN to Equal-Weight from Overweight.","DailyReturn":-0.006489,"FiveDayReturnAfter":0.006468,"FiveDayReturnBefore":0.027352},{"Ticker":"CFN","EffectiveDate":"2012-12-13","Type":"RatingNeutral","Title":"UBS maintains CFN to Buy. Target Price is $32; previously $30.","DailyReturn":-0.002125,"FiveDayReturnAfter":0.008818,"FiveDayReturnBefore":0.019675},{"Ticker":"CFN","EffectiveDate":"2012-11-20","Type":"RatingNeutral","Title":"Stifel Nicolaus initiates coverage on CFN to Buy. Target Price is $33.","DailyReturn":0.010646,"FiveDayReturnAfter":0.023939,"FiveDayReturnBefore":0.00663},{"Ticker":"CFN","EffectiveDate":"2012-11-08","Type":"EarningsRelease","Title":"After market close, CFN reports 2013 Q1's earning $0.37 per share and revenue $837MM..","DailyReturn":-0.002603,"FiveDayReturnAfter":-0.005967,"FiveDayReturnBefore":0.01235},{"Ticker":"CFN","EffectiveDate":"2012-09-10","Type":"RatingNeutral","Title":"Goldman Sachs maintains CFN to Neutral. Target Price is $28; previously $27.","DailyReturn":-0.002162,"FiveDayReturnAfter":0.003957,"FiveDayReturnBefore":0.054808},{"Ticker":"CFN","EffectiveDate":"2012-09-06","Type":"RatingNeutral","Title":"UBS maintains CFN to Buy. Target Price is $30; previously $29.","DailyReturn":0.012094,"FiveDayReturnAfter":0.043991,"FiveDayReturnBefore":0.0},{"Ticker":"CFN","EffectiveDate":"2012-08-10","Type":"RatingNeutral","Title":"Citigroup maintains CFN to Buy. Target Price is $30; previously $28.","DailyReturn":0.070004,"FiveDayReturnAfter":0.0906,"FiveDayReturnBefore":0.023056},{"Ticker":"CFN","EffectiveDate":"2012-08-09","Type":"EarningsRevenueBeat","Title":"CFN reports 2012 Q4's earning $0.51 per share and revenue $968MM. This beats analyst's estimated EPS $0.5, beats estimated revenue $959.95MM.","DailyReturn":0.006967,"FiveDayReturnAfter":0.093445,"FiveDayReturnBefore":-0.00041},{"Ticker":"CFN","EffectiveDate":"2012-05-09","Type":"EarningsRelease","Title":"After market close, CFN reports 2012 Q3's earning $0.14 per share and revenue $919MM..","DailyReturn":-0.017045,"FiveDayReturnAfter":-0.044933,"FiveDayReturnBefore":0.014114},{"Ticker":"CFN","EffectiveDate":"2012-02-21","Type":"RatingNeutral","Title":"Scotiabank maintains CFN to Sector Outperform. Target Price is $215; previously $190.","DailyReturn":0.001536,"FiveDayReturnAfter":-0.010807,"FiveDayReturnBefore":0.022516},{"Ticker":"CFN","EffectiveDate":"2012-02-17","Type":"RatingUpgrade","Title":"Morgan Keegan upgrades CFN to Outperform from Market Perform. Target Price is $31; previously $26.","DailyReturn":0.007347,"FiveDayReturnAfter":-0.001161,"FiveDayReturnBefore":0.041451}];